Inter-patient and intra-patient dose escalation strategy. Patients were... | Download Scientific Diagram
Phase I study design with dose-escalation and dose-expansion phases | Download Scientific Diagram
Definition of the dose change intervals and construction of features.... | Download Scientific Diagram
Bertrand Delsuc on X: "@BiotechRadar CUARt123 AML: RP2D definition, extensive DLT recording (differences vs ALL), dose expansion, risks assessment https://t.co/aDIcKjyNon" / X
Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - ScienceDirect
The natural history of canine occult Grade II medial patellar luxation: an observational study
Translational phase I study with biomarker-defined end points. Phase I... | Download Scientific Diagram
Phase 1 clinical trials: Designs and considerations
emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education
Moving Beyond 3+3: The Future of Clinical Trial Design | American Society of Clinical Oncology Educational Book
Phase I trials - memoinOncology
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
Bavdegalutamide (ARV-110): Phase 1 Dose Escalation and Interim ARDENT Phase 2 Dose Expansion Trial Results
Early phase clinical trials to identify optimal dosing and safety - ScienceDirect
On Biostatistics and Clinical Trials: Phase I Dose Escalation Study Design: "3 + 3 Design"
EX-99.2
Phase I Trials — Sacramento Citywide Oncology Phase I Program
Statistical controversies in clinical research: building the bridge to phase II—efficacy estimation in dose-expansion cohorts - ScienceDirect
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours | British Journal of Cancer
Traditional sequential phase versus seamless expansion trial design. a... | Download Scientific Diagram
Vaccines | Free Full-Text | Why Reaching Zero-Dose Children Holds the Key to Achieving the Sustainable Development Goals
Frontiers | Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation
First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - eClinicalMedicine
Final SAP
Alex A. Adjei, MD, PhD Designing Phase I Trials with Targeted Agents: Challenging Tradition. - ppt download
